retatrutide benefits clinical trials retatrutide CutKilo | The Thriving Black Market for

Weight regain following bariatric surgery represents a significant clinical challenge, with studies suggesting it affects a substantial proportion of patients within 25 years post-operatively

Context matters in evaluating these numbers

Meta-analyses of GLP-1 receptor agonists show that approximately 25% of weight lost consists of lean mass, with 75% coming from fat mass

Lind M, Garcia-Rodriguez LA, Booth GL, Cea-Soriano L, Shah BR, Ekeroth G, Lipscombe LL: Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study

Eligibility will likely include Medicare beneficiaries who qualify for GLP-1 medications like Wegovy and Zepbound

We really need to be asking ourselves, is it about weight loss or is it about health gain